vs
车车集团（CCG）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
车车集团的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$32.8M vs $19.6M），车车集团净利率更高（0.5% vs -177.4%，领先177.9%）
车车集团是国内领先的汽车数字化服务提供商，主营汽车保险中介服务、智能汽车售后支持、车联网技术产品等业务，服务覆盖个人车主、汽车经销商及保险合作机构，部分业务辐射东南亚市场。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CCG vs LAB — 直观对比
营收规模更大
CCG
是对方的1.7倍
$19.6M
净利率更高
CCG
高出177.9%
-177.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.8M | $19.6M |
| 净利润 | $153.6K | $-34.7M |
| 毛利率 | 5.7% | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 0.5% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $0.00 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCGLAB
| Q1 26 | $32.8M | — | ||
| Q3 25 | — | $19.6M | ||
| Q2 25 | $26.0M | $21.8M | ||
| Q1 25 | — | $40.8M | ||
| Q4 24 | $18.6M | — | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | $36.1M | $22.5M | ||
| Q1 24 | — | $45.5M |
净利润CCGLAB
| Q1 26 | $153.6K | — | ||
| Q3 25 | — | $-34.7M | ||
| Q2 25 | $-492.4K | $-33.5M | ||
| Q1 25 | — | $-26.0M | ||
| Q4 24 | $-196.7K | — | ||
| Q3 24 | — | $-26.9M | ||
| Q2 24 | $-7.6M | $-45.7M | ||
| Q1 24 | — | $-32.2M |
毛利率CCGLAB
| Q1 26 | 5.7% | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | 4.9% | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | 4.3% | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | -168.5% | ||
| Q2 25 | -2.0% | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | -4.7% | -134.5% | ||
| Q1 24 | — | -132.2% |
净利率CCGLAB
| Q1 26 | 0.5% | — | ||
| Q3 25 | — | -177.4% | ||
| Q2 25 | -1.9% | -153.7% | ||
| Q1 25 | — | -63.8% | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | — | -122.0% | ||
| Q2 24 | -21.0% | -203.3% | ||
| Q1 24 | — | -70.6% |
每股收益（稀释后）CCGLAB
| Q1 26 | $0.00 | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-0.01 | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | $-0.00 | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.0M | $129.4M |
| 总债务越低越好 | $193.3K | — |
| 股东权益账面价值 | — | $399.7M |
| 总资产 | $203.5M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCGLAB
| Q1 26 | $20.0M | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | $23.1M | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | $21.1M | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | $28.2M | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务CCGLAB
| Q1 26 | $193.3K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $690.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | $399.7M | ||
| Q2 25 | $47.1M | $424.5M | ||
| Q1 25 | — | $454.6M | ||
| Q4 24 | $49.1M | — | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | $48.6M | $510.3M | ||
| Q1 24 | — | $577.3M |
总资产CCGLAB
| Q1 26 | $203.5M | — | ||
| Q3 25 | — | $539.6M | ||
| Q2 25 | $177.3M | $557.0M | ||
| Q1 25 | — | $579.6M | ||
| Q4 24 | $177.7M | — | ||
| Q3 24 | — | $681.5M | ||
| Q2 24 | $139.3M | $708.7M | ||
| Q1 24 | — | $777.7M |
负债/权益比CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | $-22.2M | ||
| Q2 25 | $-44.7M | $-20.7M | ||
| Q1 25 | — | $-30.3M | ||
| Q4 24 | $-15.8M | — | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | $-1.0K | $-39.0M | ||
| Q1 24 | — | $-62.5M |
自由现金流CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | $-16.0M | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | $-1.1K | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | -85.9% | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | -0.0% | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度CCGLAB
| Q1 26 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | 0.0% | 8.6% | ||
| Q1 24 | — | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCG
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
